Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
US Army
Fuji
Fish and Richardson
Boehringer Ingelheim

Generated: September 24, 2019

DrugPatentWatch Database Preview

Siponimod fumaric acid - Generic Drug Details

  Try a free trial


See Plans and Pricing

« Back to Dashboard

What are the generic sources for siponimod fumaric acid and what is the scope of siponimod fumaric acid freedom to operate?

Siponimod fumaric acid is the generic ingredient in one branded drug marketed by Novartis Pharms Corp and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Siponimod fumaric acid has one hundred and twenty-nine patent family members in thirty-seven countries.

One supplier is listed for this compound.

Summary for siponimod fumaric acid
International Patents:129
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
DailyMed Link:siponimod fumaric acid at DailyMed

US Patents and Regulatory Information for siponimod fumaric acid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp MAYZENT siponimod fumaric acid TABLET;ORAL 209884-001 Mar 26, 2019 RX Yes No   Try a Free Trial   Try a Free Trial Y Y   Try a Free Trial
Novartis Pharms Corp MAYZENT siponimod fumaric acid TABLET;ORAL 209884-002 Mar 26, 2019 RX Yes Yes   Try a Free Trial   Try a Free Trial   Try a Free Trial
Novartis Pharms Corp MAYZENT siponimod fumaric acid TABLET;ORAL 209884-001 Mar 26, 2019 RX Yes No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Novartis Pharms Corp MAYZENT siponimod fumaric acid TABLET;ORAL 209884-002 Mar 26, 2019 RX Yes Yes   Try a Free Trial   Try a Free Trial   Try a Free Trial
Novartis Pharms Corp MAYZENT siponimod fumaric acid TABLET;ORAL 209884-002 Mar 26, 2019 RX Yes Yes   Try a Free Trial   Try a Free Trial Y Y   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Teva
Moodys
Express Scripts
Queensland Health
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.